Estimating the Cutoff Points of Time-Dependent Risk Factors by Using Joint Modeling of Longitudinal and Time-to-Event Data: A 14-Year Follow-up Study—Tehran Lipid and Glucose Study
Restricted accessResearch articleFirst published online November, 2019
Estimating the Cutoff Points of Time-Dependent Risk Factors by Using Joint Modeling of Longitudinal and Time-to-Event Data: A 14-Year Follow-up Study—Tehran Lipid and Glucose Study
Diagnostic accuracy and optimal cutoff points of risk factors is one of the important issues in medical decisions. In order to reassess the cutoff points of markers, longitudinal and time-to-event data of elderly individuals were collected repeatedly through 3 follow-up stages in the Tehran Lipid and Glucose Study. Time-dependent area under the ROC (receiver operating characteristic) curves (AUCs) based on the joint modeling of longitudinal and time-to-event data technique were measured. AUCs were considered to evaluate the discriminative potential of the models. The joint model produced higher AUC values than the Cox model; therefore, accuracy was improved although it is computationally complicated. The results had some differences with the thresholds reported in guidelines due to specificity to the population and/or the means of estimation methods. The estimated cutoff points with regard to sex can be used as a guideline for the Iranian elderly population.
DECODE Study Group; European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?Diabetes Care. 2003;26:688-696.
2.
MuntnerPCareyRMGiddingS, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137:109-118.
3.
JamesPAOparilSCarterBL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi:10.1001/jama.2013.284427
4.
Pastor-BarriusoRBanegasJRDamianJAppelLJGuallarE.Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med. 2003;139:731-739.
5.
KangDGJeongMHAhnY, et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci. 2009;24:800-806.
6.
American Diabetes Association. Standards of medical care in Diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33:97-111.
7.
HoegJMSviridovDDTennysonGE, et al. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res. 1990;31:1761-1769.
8.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
9.
AlbertiKGZimmetPShawJ.Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
10.
ShakeriNEskandariFHajsheikholeslamiFGhanbarianAAziziF.On the estimation of Survival time and contributory risk factors in the elderly participants in the Tehran Lipid and Glucose study. A 10 year follow-up. J Paramed Sci. 2011;2:2-8.
11.
ShakeriNEskandariFHajsheikholeslamiFMomenanAAAziziF.Life expectancy of Tehranian elderly and its attributable risk factors: the Tehran Lipid and Glucose Study (1998-2011). Iran J Epidemiol. 2014;9:9-16.
12.
Assaad-KhalilSHZakiARehimAA, et al. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Prim Care Diabetes. 2015;9:297-303.
13.
DelavariAForouzanfarMHAlikhaniSSharifianAKelishadiR.First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32:1092-1097.
14.
YoonYSOhSW.Optimal waist circumference cutoff values for the diagnosis of abdominal obesity in Korean adults. Endocrinol Metab (Seoul). 2014;29:418-426.
15.
FrohlichED.The fifth Joint National Committee report on the detection, evaluation and treatment of high blood pressure. J Am Coll Cardiol. 1993;22:621-622.
16.
SchutteAE.What are the financial implications of the 2017 AHA/ACC high blood pressure guideline?Eur J Prev Cardiol. 2018;25:1109-1110.
17.
VaucherJMarques-VidalPWaeberGVollenweiderP.Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management. Eur J Prev Cardiol. 2018;25:1111-1113.
18.
CattaneoMMalighettiPSpinelliD.Estimating receiver operative characteristic curves for time-dependent outcomes: the Stroccurve package. Stata J. 2018;17:1015-1023. doi:10.1177/1536867X1701700415
19.
YuenHPMackinnonANelsonB.A new method for analyzing transition to psychosis: joint modeling of time-to-event outcome with time-dependent predictors. Int J Methods Psychiatr Res. 2018;27:e1588.
20.
StamenicD.Joint Modelling of Longitudinal and Time-to-Event Data: Analysis of Predictive Factors of Graft Outcomes in Kidney Transplant Recipients. Human Health and Pathology [thesis]. Limoges, France: Université de Limoges; 2018. https://tel.archives-ouvertes.fr/tel-01930746/document
21.
RizopoulosD.Joint Models for Longitudinal and Time-to Event Data: With Applications in R. London, England: Chapman & Hall/CRC; 2012.
22.
HeagertyPZhengY.Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92-105.
23.
ZhengYHeagertyPJ.Prospective accuracy for longitudinal markers. Biometrics. 2007;63:332-341.
24.
RizopoulosD.Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data. Biometrics. 2011;67:819-829.
25.
YoudenW.Index for rating diagnostic tests. Cancer. 1950;3:32-35.
26.
HadaeghFHaratiHGhanbarianAAziziF.Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil. 2006;13:571-577.
27.
AziziFGhanbarianAMomenanAA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.
